Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Targacept CEO steps down, leaves board
Bloomberg Businessweek
Tuesday, June 5, 2012 - 12:20pm
tags:
Targacept, Pharma CEOs
U.S. on track to approve more cancer drugs in 2012
Reuters
Tuesday, June 5, 2012 - 12:19pm
tags:
FDA, cancer, drug approvals
The Obesity Race: Update, Part 1
Seeking Alpha
Tuesday, June 5, 2012 - 12:16pm
tags:
Vivus, Qnexa, Arena Pharmaceuticals, lorcaserin, Orexigen, Contrave
Complete Genomics cuts jobs, starts review
Yahoo/AP
Tuesday, June 5, 2012 - 12:14pm
tags:
layoffs, Complete Genomics
Dyax announces partnership with taiba for Kalbitor
The Fly on the Wall
Tuesday, June 5, 2012 - 12:13pm
tags:
Dyax, Kalbitor, hereditary angiodema, Middle East, taiba ME
Vivus says no EU ruling on Qnexa before September
Yahoo/AP
Tuesday, June 5, 2012 - 12:12pm
tags:
Vivus, Europe, Qnexa
Merck: Dividend Growth Investors Beware
Seeking Alpha
Tuesday, June 5, 2012 - 12:11pm
tags:
Merck, dividends
Merck, Amgen Solid 'Buys' Against GlaxoSmithKline
Seeking Alpha
Tuesday, June 5, 2012 - 12:10pm
tags:
GSK, Merck, Amgen
Did Dendreon’s Giant Stockholders Sell on Fears of J&J’s Drug?
Wall St. Cheat Sheet
Tuesday, June 5, 2012 - 11:06am
tags:
Dendreon, JNJ, Zytiga, prostate cancer, Provenge
Amylin Said To Draw Bids Of $25 To $29 A Share In First Round
Bloomberg
Tuesday, June 5, 2012 - 9:39am
tags:
Amylin, M&A, Sanofi, AstraZeneca, Merck, Bristol-Myers Squibb
Allergan wins new trial in big Botox damages case
Reuters
Tuesday, June 5, 2012 - 9:36am
tags:
Allergan, lawsuits, Botox
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tuesday, June 5, 2012 - 9:34am
tags:
cabozantinib, Exelixis, BMS-936558, MDX-1106, cancer, anti-PD-1 immunotherapy, Bristol-Myers Squibb
3 Reasons To Buy Aegerion Pharmaceuticals
Seeking Alpha
Tuesday, June 5, 2012 - 9:33am
tags:
Aegerion, PerkinElmer, Abbott Laboratories
Bristol Immune Drug Success In Cancer May Spur Industry Race
Bloomberg
Monday, June 4, 2012 - 6:03pm
tags:
Bristol-Myers Squibb, lung cancer, skin cancer, kidney cancer
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Bloomberg
Monday, June 4, 2012 - 6:02pm
tags:
GSK, melanoma, dabrafenib, trametinib
Should The J&J Zytiga Trial Have Ended Early?
Pharmalot
Monday, June 4, 2012 - 6:00pm
tags:
JNJ, Zytiga, prostate cancer
Will Shares Of Aastrom Really Triple From Today's Levels Within A Year?
Seeking Alpha
Monday, June 4, 2012 - 5:58pm
tags:
Aastrom Biosciences
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Monday, June 4, 2012 - 5:57pm
tags:
ONYX Pharmaceuticals, Anthony Coles, Bayer, regorafenib, gastrointestinal cancer
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Monday, June 4, 2012 - 5:54pm
tags:
Immunogen, Roche, breast cancer, T-DM1
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
Monday, June 4, 2012 - 5:46pm
tags:
Teva Pharmaceuticals, Treanda, ASCO, non-Hodgkin's lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.